Lingkang Pharmaceutical: Cancel 8.92M shares

L kang Pharmaceutical announces that 8.9159 million shares held in the company’s dedicated repurchase securities account will be canceled, with the cancellation date set for April 22, 2026.
After this share cancellation is completed, the company’s total share capital will change from 721 million shares to 712 million shares, and the company’s registered capital will change from 721 million yuan to 712 million yuan.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin